Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes


Yanyali A., Aytug B., Horozoglu F. , Nohutcu A. F.

AMERICAN JOURNAL OF OPHTHALMOLOGY, vol.144, no.1, pp.124-126, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 144 Issue: 1
  • Publication Date: 2007
  • Doi Number: 10.1016/j.ajo.2007.02.048
  • Title of Journal : AMERICAN JOURNAL OF OPHTHALMOLOGY
  • Page Numbers: pp.124-126

Abstract

PURPOSE: To report the visual acuity (VA) and foveal thickness (FT) changes after intravitreal bevacizumab for diabetic macular edema (DME) in previously vitrectomized eyes.